Skip to main content
Top
Published in: Abdominal Radiology 1/2018

01-01-2018

LI-RADS categories: concepts, definitions, and criteria

Authors: Cynthia Santillan, Victoria Chernyak, Claude Sirlin

Published in: Abdominal Radiology | Issue 1/2018

Login to get access

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) was created to provide a standardized way to both assess and communicate the likelihood of benignity or malignancy of observations seen in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS categories allow radiologists to convey the full spectrum of concern for malignancy, from definitely benign to definitely HCC. Additional categories are available for non-categorizable observations, observations that are concerning for a non-HCC malignancy, and the presence of tumor in vein. The goal of this paper is to discuss the LI-RADS categories, including criteria for each category, and point out changes to the categories from prior versions of LI-RADS.
Literature
2.
3.
go back to reference Choi SH, et al. (2016) Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51(8):483–490CrossRefPubMed Choi SH, et al. (2016) Liver Imaging Reporting and Data System v2014 with gadoxetate disodium-enhanced magnetic resonance imaging: validation of LI-RADS category 4 and 5 criteria. Invest Radiol 51(8):483–490CrossRefPubMed
4.
go back to reference Cruite I, Tang A, Sirlin CB (2013) Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol 201(1):41–55CrossRefPubMed Cruite I, Tang A, Sirlin CB (2013) Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol 201(1):41–55CrossRefPubMed
5.
go back to reference Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127(5 Suppl 1):S261–S267CrossRefPubMed Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127(5 Suppl 1):S261–S267CrossRefPubMed
6.
go back to reference Bruix J, Sherman M, American D (2011) Association for the Study of Liver, Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral Bruix J, Sherman M, American D (2011) Association for the Study of Liver, Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022CrossRefPubMedPubMedCentral
7.
go back to reference Darnell A, et al. (2015) Liver Imaging Reporting and Data System with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed Darnell A, et al. (2015) Liver Imaging Reporting and Data System with MR imaging: evaluation in nodules 20 mm or smaller detected in cirrhosis at screening US. Radiology 275(3):698–707CrossRefPubMed
Metadata
Title
LI-RADS categories: concepts, definitions, and criteria
Authors
Cynthia Santillan
Victoria Chernyak
Claude Sirlin
Publication date
01-01-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1334-x

Other articles of this Issue 1/2018

Abdominal Radiology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.